Skip to main content

Agilent Announces Planned Retirement of Principal Accounting Officer

Tipranks - Sat Mar 7, 3:50PM CST

Claim 70% Off TipRanks Premium

Agilent ( (A) ) has provided an update.

On March 5, 2026, Agilent Technologies said Vice President, Corporate Controller and Principal Accounting Officer Rodney Gonsalves plans to retire from his roles in January 2027, with the exact date to be set later. The company emphasized that his departure does not arise from any dispute over accounting, financial reporting, internal controls, or operations, and the long lead time is intended to support a thorough search for a successor and an orderly transition of responsibilities.

The planned retirement underscores Agilent’s effort to manage senior finance leadership changes without disrupting its reporting processes or internal governance. By signaling stability in its accounting practices and providing for an extended handover, the company aims to reassure investors and other stakeholders that continuity and control in its financial function will be maintained despite the upcoming leadership change.

The most recent analyst rating on (A) stock is a Buy with a $160.00 price target. To see the full list of analyst forecasts on Agilent stock, see the A Stock Forecast page.

Spark’s Take on A Stock

According to Spark, TipRanks’ AI Analyst, A is a Neutral.

The score reflects solid underlying financial profitability and supportive FY26 guidance (including higher EPS outlook and planned margin expansion), partially offset by margin/cash-flow softness. The biggest drag is weak technical momentum with the stock trading below major moving averages, while valuation appears somewhat premium for the current setup.

To see Spark’s full report on A stock, click here.

More about Agilent

Agilent Technologies, Inc., a U.S.-based company, operates in the life sciences, diagnostics, and applied chemical markets, providing analytical instruments, software, services, and consumables to laboratories worldwide. The company focuses on enabling scientific research, clinical diagnostics, and quality control across pharmaceuticals, biotechnology, chemical, and related industries, positioning itself as a key supplier in high‑precision measurement and analysis.

Average Trading Volume: 2,220,418

Technical Sentiment Signal: Sell

Current Market Cap: $33.38B

Learn more about A stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.